BRITTANY MALONEY: Open Payments
NPI 1801277702 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$393 in 18 payments from 11 companies in 2025. Trend: 2023 $606 · 2024 $317 · 2025 $393
Food & beverage: $393
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 3 | $84 |
| ABBVIE INC. | 3 | $57 |
| Madrigal Pharmaceuticals | 1 | $39 |
| Ardelyx, Inc. | 1 | $32 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $32 |
| Novo Nordisk Inc | 1 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $29 |
| Ipsen Biopharmaceuticals, Inc | 1 | $26 |
| Janssen Biotech, Inc. | 1 | $25 |
| Gilead Sciences, Inc. | 1 | $20 |
Products named: XELJANZ, REZDIFFRA, LINZESS, IBSRELA, XIFAXAN, Wegovy, EOHILIA, VELSIPITY.
Industry payments across NY — which companies pay providers there.
